vyne stock forecast zacks

Find out the current price target and stock forecast for VYNE Therapeutics VYNE. Zacks proprietary data indicates that VYNE Therapeutics Inc.

Vyne Therapeutics Inc Vyne Stock Price Quote News Stock Analysis

The average price target is 150 with a high forecast of 150 and a low forecast.

. 16 2021 when the stock price was at 178. Get the latest VYNE Therapeutics Inc VYNE detailed stock quotes stock data Real-Time ECN charts. Based on 1 Wall Street analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months.

Get a real-time VYNE Therapeutics Inc. Zacks Investment Research upgraded shares of VYNE Therapeutics NASDAQVYNE from a sell rating to a hold rating in a report published on Thursday morning. According to 1 Wall Street analyst that have issued a 1 year VYNE price target the average VYNE price target is 150 with the highest VYNE stock price forecast at 150 and the lowest.

VYNE might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank 2 Buy. On average they predict. Our latest prediction for VYNE Therapeutics Incs stock price was made on the Aug.

Zacks Investment Research upgraded. View VYNE Therapeutics Inc VYNE investment stock information. Their VYNE share price forecasts range from 150 to 150.

According to 11 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 183457. The lowest target is 152. VYNE stock forecast.

In the short term. Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the VYNE shares relative to the market in. VYNE stock price quote with breaking news financials statistics charts and more.

3 Wall Street analysts have issued 12-month target prices for VYNE Therapeutics stock.

Is A Surprise Coming For Stoke Therapeutics Stok This Earnings Season